BioSig Technologies Q1 2025 10-Q Filed
Ticker: STEX · Form: 10-Q · Filed: May 19, 2025 · CIK: 1530766
| Field | Detail |
|---|---|
| Company | Biosig Technologies, Inc. (STEX) |
| Form Type | 10-Q |
| Filed Date | May 19, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, preferred-stock
Related Tickers: BSGM
TL;DR
BioSig Q1 10-Q dropped. Shows preferred stock details as of 3/31/25.
AI Summary
BioSig Technologies, Inc. filed its quarterly report for the period ending March 31, 2025. The company, located at 55 Greens Farms Road in Westport, CT, is involved in the electromedical and electrotherapeutic apparatus industry. The filing details various preferred stock series, including Series C Nine Percentage Convertible Preferred Stock, Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, and Series F Preferred Stock, as of March 31, 2025, and December 31, 2024.
Why It Matters
This filing provides investors with an update on BioSig Technologies' financial position and capital structure as of the first quarter of 2025, including details on their preferred stock.
Risk Assessment
Risk Level: low — This filing is a routine quarterly report and does not contain significant new risk factors or negative financial developments.
Key Numbers
- 20250331 — Reporting Period End Date (Indicates the end of the fiscal quarter for this 10-Q filing.)
- 20250519 — Filing Date (The date the 10-Q report was officially submitted to the SEC.)
Key Players & Entities
- BioSig Technologies, Inc. (company) — Filer of the 10-Q report
- March 31, 2025 (date) — End of the reporting period
- 55 Greens Farms Road, Westport, CT (location) — Company's business and mailing address
- Series C Nine Percentage Convertible Preferred Stock (security) — Type of preferred stock detailed in the filing
- Series A Preferred Stock (security) — Type of preferred stock detailed in the filing
FAQ
What is the primary business of BioSig Technologies, Inc.?
BioSig Technologies, Inc. is involved in the ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS industry, as indicated by its SIC code 3845.
What is the fiscal year end for BioSig Technologies, Inc.?
The fiscal year end for BioSig Technologies, Inc. is December 31st.
What specific types of preferred stock are mentioned in the filing for March 31, 2025?
The filing mentions Series C Nine Percentage Convertible Preferred Stock, Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, and Series F Preferred Stock as of March 31, 2025.
What is the SEC file number for BioSig Technologies, Inc.?
The SEC file number for BioSig Technologies, Inc. is 001-38659.
When was this 10-Q filing submitted?
This 10-Q filing was submitted on May 19, 2025.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 19, 2025 regarding BioSig Technologies, Inc. (STEX).